Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.

Inga Waltl; Claus Zehetner; Christof Seifarth; Florian Handle; Gerhard F Kieselbach; Reinhard Angermann; Martina T Kralinger

doi:10.1080/02713683.2017.1403632

Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.

Inga Waltl
, Claus Zehetner
, Christof Seifarth
, Florian Handle
, Gerhard F Kieselbach
, Reinhard Angermann
, Martina T Kralinger

Department of Ophthalmology

Research output: Contribution to journal › Original Article › peer-review

8 Citations (Web of Science)

Original language	English
Pages (from-to)	368-375
Journal	CURRENT EYE RESEARCH
Volume	43
Issue number	3
DOIs	https://doi.org/10.1080/02713683.2017.1403632
Publication status	Published - 2018

Keywords

MACULAR EDEMA
VEGF-TRAP
ANTI-VEGF
RANIBIZUMAB
BEVACIZUMAB
DEGENERATION
EXPRESSION
INJECTION
RECEPTOR
ANGIOGENESIS

Access to Document

10.1080/02713683.2017.1403632

Cite this

Waltl, I., Zehetner, C., Seifarth, C., Handle, F., Kieselbach, G. F., Angermann, R., & Kralinger, M. T. (2018). Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy. CURRENT EYE RESEARCH , 43(3), 368-375. https://doi.org/10.1080/02713683.2017.1403632

Waltl, Inga ; Zehetner, Claus ; Seifarth, Christof et al. / Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy. In: CURRENT EYE RESEARCH 2018 ; Vol. 43, No. 3. pp. 368-375.

@article{91e13a84b2934634acc4ff3765fdc052,

title = "Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.",

keywords = "MACULAR EDEMA, VEGF-TRAP, ANTI-VEGF, RANIBIZUMAB, BEVACIZUMAB, DEGENERATION, EXPRESSION, INJECTION, RECEPTOR, ANGIOGENESIS",

author = "Inga Waltl and Claus Zehetner and Christof Seifarth and Florian Handle and Kieselbach, \{Gerhard F\} and Reinhard Angermann and Kralinger, \{Martina T\}",

year = "2018",

doi = "10.1080/02713683.2017.1403632",

language = "English",

volume = "43",

pages = "368--375",

journal = "CURRENT EYE RESEARCH ",

issn = "0271-3683",

number = "3",

}

Waltl, I, Zehetner, C, Seifarth, C, Handle, F, Kieselbach, GF, Angermann, R & Kralinger, MT 2018, 'Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.', CURRENT EYE RESEARCH , vol. 43, no. 3, pp. 368-375. https://doi.org/10.1080/02713683.2017.1403632

Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy. / Waltl, Inga; Zehetner, Claus; Seifarth, Christof et al.
In: CURRENT EYE RESEARCH , Vol. 43, No. 3, 2018, p. 368-375.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.

AU - Waltl, Inga

AU - Zehetner, Claus

AU - Seifarth, Christof

AU - Handle, Florian

AU - Kieselbach, Gerhard F

AU - Angermann, Reinhard

AU - Kralinger, Martina T

PY - 2018

Y1 - 2018

KW - MACULAR EDEMA

KW - VEGF-TRAP

KW - ANTI-VEGF

KW - RANIBIZUMAB

KW - BEVACIZUMAB

KW - DEGENERATION

KW - EXPRESSION

KW - INJECTION

KW - RECEPTOR

KW - ANGIOGENESIS

U2 - 10.1080/02713683.2017.1403632

DO - 10.1080/02713683.2017.1403632

M3 - Original Article

C2 - 29172741

SN - 0271-3683

VL - 43

SP - 368

EP - 375

JO - CURRENT EYE RESEARCH

JF - CURRENT EYE RESEARCH

IS - 3

ER -

Waltl I, Zehetner C, Seifarth C, Handle F, Kieselbach GF, Angermann R et al. Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy. CURRENT EYE RESEARCH . 2018;43(3):368-375. doi: 10.1080/02713683.2017.1403632